Followers | 1324 |
Posts | 128332 |
Boards Moderated | 1 |
Alias Born | 08/28/2009 |
Monday, March 19, 2018 2:32:27 PM
My opinions and comments are exactly that. They are not a recommendation to either buy or sell any security.
Recent NFX News
- Nuformix PLC Result of AGM • RNS Regulatory News • 03/19/2024 02:39:02 PM
- Nuformix announces subscription to raise GBP150,000 • Alliance News • 03/01/2024 10:31:01 AM
- Nuformix PLC Subscription to raise £150,000 • RNS Regulatory News • 03/01/2024 07:00:04 AM
- Nuformix PLC Posting of Annual Report and Notice of AGM • UK Regulatory • 01/15/2024 11:30:00 AM
- Nuformix narrows annual loss as develops drug assets • Alliance News • 01/03/2024 10:16:07 AM
- Nuformix PLC Results for the period ended 30 September 2023 • UK Regulatory • 01/03/2024 07:00:00 AM
- Nuformix PLC NXP001 Update • UK Regulatory • 12/18/2023 07:00:00 AM
- Nuformix gets patent in Japan for pulmonary fibrosis treatment NXP002 • Alliance News • 10/23/2023 11:38:39 AM
- Nuformix PLC Notice of Allowance of NXP002 Patent in Japan • UK Regulatory • 10/23/2023 06:04:00 AM
- Nuformix to receive milestone payments from Oxilio pact • Alliance News • 09/18/2023 09:20:54 AM
- Nuformix PLC NXP001 Update • UK Regulatory • 09/18/2023 06:00:00 AM
- Nuformix PLC Result of Annual General Meeting • UK Regulatory • 08/24/2023 12:22:00 PM
- Nuformix PLC Notice of AGM • UK Regulatory • 07/31/2023 01:00:00 PM
- Nuformix PLC Holding(s) in Company • UK Regulatory • 07/26/2023 01:55:00 PM
- Nuformix PLC Investor Online Q&A • RNS Non-Regulatory • 06/02/2023 06:00:00 AM
- Nuformix PLC Change of Auditor • UK Regulatory • 05/25/2023 06:00:00 AM
- Nuformix loss narrows; near-term goal to focus on NXP002 asset • Alliance News • 05/22/2023 11:45:14 AM
- Nuformix PLC Unaudited Interim Report • UK Regulatory • 05/22/2023 06:00:00 AM
- Nuformix says NXP002 shows anti-inflammatory effect • Alliance News • 05/18/2023 01:31:17 PM
- Nuformix PLC NXP002 Inflammation and Duration of Action Update • UK Regulatory • 05/18/2023 06:00:00 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM